Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Risperidone and reversible neutropenia: a negative rechallenge

G Bondolfi1, P Morena, D R Dascal

  • 1Département Universitaire de Psychiatrie Adulte (DUPA), Service Hospitalo-ambulatoire A, Prilly-Lausanne, Switzerland.

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|August 1, 1996
PubMed
Summary

Risperidone rechallenge therapy did not cause hematological abnormalities in a schizophrenic patient previously experiencing neutropenia. This suggests potential safety for risperidone (RIS) in patients with prior reversible neutropenia.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and tolerance of combination of monoamine oxidase inhibitors and direct dopamine agonists in adults and older adults with highly resistant depression.

L'Encephale·2023
Same author

Hyper/neuroinflammation in COVID-19 and suicide etiopathogenesis: Hypothesis for a nefarious collision?

Neuroscience and biobehavioral reviews·2022
Same author

Impact of the first wave of the COVID-19 pandemic on French Health students.

L'Encephale·2022
Same author

Misdiagnosis in three boys with predominantly hyperactive ADHD.

L'Encephale·2020
Same author

Racing and crowded thoughts in mood disorders: A data-oriented theoretical reappraisal.

L'Encephale·2020
Same author

Type A competitiveness traits correlate with downregulation of c-Fos expression in patients with type 1 diabetes.

Diabetes & metabolism·2018

Area of Science:

  • Pharmacology
  • Hematology
  • Psychiatry

Background:

  • Risperidone is an antipsychotic medication used to treat schizophrenia.
  • Neutropenia, a decrease in neutrophils, can be a rare side effect of some medications.
  • Previous episodes of neutropenia may raise concerns about drug re-administration.